Articles

• All
• CVD
• CKD
• Dialysis
• SGLT2i
• Hypertension
• Hyperglycaemia
• AKI
• RAAS
• Anaemia
• Transplantation

• 

  How low should we go? Optimal blood pressure targets for people with type 2 diabetes to reduce kidney and cardiovascular outcomes

  26 Feb 2026

  • Hypertension
  • CKD
  • Hyperglycaemia

• 

  Blood pressure levels and outcomes in type 2 diabetes

  25 Feb 2026

  • Hypertension
  • Other conditions
  • Hyperglycaemia

• 

  FINE-HEART: Effects of finerenone on morbidity and mortality in CKD

  3 Nov 2025

  • CKD
  • CVD
  • Hyperglycaemia

• 

  Use and safety of finerenone in a routine setting: first interim results from FINE-REAL

  26 Oct 2024

  • CKD
  • Hyperglycaemia

• 

  A promising FLOW of repurposed pharmacological therapies in people with CKD in type 2 diabetes

  12 Jul 2024

  • CKD
  • CVD
  • Hyperglycaemia
  • Editorial

• 

  Semaglutide improves chronic kidney disease in people with type 2 diabetes

  11 Jul 2024

  • CKD
  • Hyperglycaemia

• 

  SGLT2i kidney outcome trial participants vs a real-world population

  11 May 2024

  • SGLT2i
  • CKD
  • Hyperglycaemia

• 

  SGLT2 inhibitors versus GLP-1 receptor agonists for renal patients: does it matter?

  14 Mar 2024

  • SGLT2i
  • Hyperglycaemia
  • Editorial

• 

  Novel antidiabetes drugs improve composite renal outcomes

  13 Mar 2024

  • CKD
  • Hyperglycaemia
  • SGLT2i